Skip to main content
. 2021 Jul 12;12:702636. doi: 10.3389/fimmu.2021.702636

Figure 1.

Figure 1

A workflow for developing and administering gene therapy. Novel gene therapy approaches involve (A) the identification of therapeutic targets, (B) an ex vivo gene modification step to create a transduced drug product (left) or the production of an in vivo product (right), and (C) the infusion of these products into patients following myeloablative conditioning.